PDCD1LG2 and neoplasm: This aligns with our broader analysis implicating chemokine ligands (CCL family), immune checkpoints (PD‐L1/CD274, PDCD1LG2, HAVCR2), and cell surface markers in shaping tumor immune phenotypes.